Navigation Links
BioMarin to Host Third Quarter 2010 Financial Results Conference Call and Webcast on Thursday, October 28 at 5:00 p.m. ET
Date:10/7/2010

NOVATO, Calif., Oct. 7 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, October 28, at 5:00 p.m. ET to discuss third quarter 2010 financial results.U.S. / Canada Dial-in Number:  866.202.3048International Dial-in Number:  617.213.8843Participant Code: 60493555Replay Dial-in Number: 888.286.8010Replay International Dial-in Number: 617.801.6888Replay Code: 45911037Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in clinical development for the treatment of MPS IVA and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is curre
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMarin to Present at the Barclays Capital Global Healthcare Conference
2. BioMarins Chief Executive Jean-Jacques Bienaime to Receive Most Admired CEO Award From San Francisco Business Times
3. BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday, October 28 at 5:00 p.m. ET
4. BioMarin to Present at the Morgan Stanley Healthcare Conference
5. BioMarin to Present at the Baird Healthcare Conference
6. BioMarin to Present at the Jefferies Healthcare Conference
7. BioMarin to Present at the Goldman Sachs Healthcare Conference
8. BioMarin to Present at the Deutsche Bank Health Care Conference
9. BioMarin to Present at the Baird Growth Stock Conference
10. BioMarin Announces First Quarter 2009 Financial Results
11. BioMarin to Host First Quarter 2009 Financial Results Conference Call and Webcast on Thursday, April 30 at 5:00 p.m. ET (23:00 CET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Mich. , May 6, 2015 Paradigm ... will give the keynote address at the International Society ... in Phoenix, AZ at 9:45 ... The Odyssey" will focus on the historic and critical ... in shaping our personalized medicine revolution.  Furthermore, he will ...
(Date:5/6/2015)... California (PRWEB) May 06, 2015 ... Dots, a type of nanomaterial with diameter ranging ... product in the global nanophotonics materials market. The ... quantum dots due to quantum confinement effect render ... a wide range of scientific, technological, and commercial ...
(Date:5/6/2015)... , May 6, 2015  Northwest Biotherapeutics (NASDAQ: NWBO) ... therapies for solid tumor cancers, today announced that Linda Powers ... the Company,s DCVax cancer vaccine platform for solid tumor cancers ... 7, 2015.   , , , ... , , , TIME: , , , 12:15 PM EDT ...
(Date:5/6/2015)... , May 6, 2015 ... membrane specialist, announced today that it has signed an ... Ethanol, Inc. (Nasdaq: PEIX ) for the delivery of an industrial ... reduce the consumption of water, energy and ... output. This project is fully ...
Breaking Biology Technology:Paradigm CEO Dr. Robert Penny Presents Keynote Address at 2015 ISBER Conference 2Paradigm CEO Dr. Robert Penny Presents Keynote Address at 2015 ISBER Conference 3Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 3NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7 2NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7 3Whitefox Signs Agreement With Pacific Ethanol Inc. 2
... U.S. District Court for the Western District of Wisconsin ... preventing the pharmaceutical company from further sales or use of ... by Innogenetics , a biopharmaceutical company based in Gent, ... $7 million damage verdict against Abbott. In September of 2006, ...
... With plans to erect as many as five more buildings ... thinking about needs well beyond its existing base of 2,500 ... chief administrative officer, said the company anticipates adding 1,500 more ... of 2,500. In addition, there remains plenty of room on ...
... next to a word as a way to create an icon ... possible, the chances of creating a long-lasting, global iconic mark is ... of its unique name, and for that reason you have examples ... not iTV. , ,Terms like interactive and portable were behind the ...
Cached Biology Technology:Epic Systems will build well beyond current staff size 2The I of the storm: iPhones, iPains, and iProblems 2The I of the storm: iPhones, iPains, and iProblems 3The I of the storm: iPhones, iPains, and iProblems 4
(Date:4/1/2015)... 1, 2015   Medisafe ™, the leading global ... iOS and Android smartphones and ... into the platform to allow patients to track and ... first time, patients will be able to visualize in ... important biometrics, such as glucose levels and blood pressure. ...
(Date:3/30/2015)... Mar. 26, 2015 Research and Markets ... "Global Gesture Recognition Market in Automotive Sector 2014-2018" ... forecast the Global Gesture Recognition market in Automotive Sector ... period 2013-2018. Gesture recognition is the ability ... gestures of an individual. Gesture recognition technology can be ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and Markets ... "Face and Voice Biometrics - Global Strategic Business Report" report ... for Face and Voice Biometrics in US$ Thousands by the following ... analytics for the US, Canada , ... , Middle East & ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... psychologists have determined for the first time that a gene ... sensitivity as well. Their study ... associated with physical pain, is related to how much social ... with a rare form of the gene are more sensitive ...
... Weitao, a researcher in the College of Sciences, Department of ... making great strides in a project that was funded one ... professor in the South Texas Center for Emerging Infectious Diseases ... threatens the health of military personnel in the Middle East ...
... for manipulating DNA in the laboratory may soon ... capable of cleaving single-stranded DNA, researchers at the ... DNA cleavage with the sequence-selectivity and site-selectivity required ... work suggests that deoxyribozymes have significant potential as ...
Cached Biology News:Researchers find genetic link between physical pain and social rejection 2Researchers find genetic link between physical pain and social rejection 3UTSA biology researchers demystify elusive war zone bacterium 2Newly found DNA catalysts cleave DNA with water molecule 2
Peroxidase Protective Buffer is a diluent formulated to stabilize the activity of Chemicon horseradish peroxidase (HRP)-antibody conjugates at high conjugate dilution for extended periods....
... is a highly nutritious versatile medium which ... to the inclusion of both Tryptone and ... of many fastidious organisms without the addition ... United States Pharmacopeia standards for use in ...
... and endothelial cells-directed transfection reagent ... peptide-conjugated polyethylenimine which allows targeted ... and endothelial cells. Integrins are ... and cell-matrix adhesion processes. Many ...
... WinMelt software is used to ... any DNA sequence up to ... optimizing placement of primers and ... by denaturing gradient gel electrophoresis ...
Biology Products: